Gary Peters spent part of this week grilling the Postmaster General on whether states that refuse to hand over voter rolls will still get their mail-in ballots delivered. The clip went viral on Bluesky. Twenty-four posts and counting, most of them furious, quoting his line: "You're making a decision that people cannot vote by mail. That's unacceptable." Meanwhile, a housing bill he co-sponsored is heading to the House floor for a final vote. The senator is having a moment. His brokerage account, for its part, is having a different kind of moment entirely, one involving PepsiCo, J.M. Smucker, and a freshly dumped position in Corteva Agriscience, a company that sits squarely in the jurisdiction of a committee he serves on.
The Housing Bill, Briefly
The 21st Century ROAD to Housing Act is Peters's marquee item of the moment. He voted to proceed on June 16, voted for cloture on June 18, and voted Yea on final passage June 22. Three votes, same direction, same bill. The legislation is now headed to the House for a final vote. Peters's committee assignments don't include housing finance or HUD-adjacent oversight, so there's no conflict-of-interest angle on the votes themselves. He's just a senator voting on a bill he likes. That's the whole story on the housing front.
The postal service confrontation is the livelier news peg. Bluesky was running hot with it, senators pressing the Postmaster General on mail ballot delivery, Peters asking a yes-or-no question and not getting one. The social buzz suggests his constituents noticed. None of that has a stock-market angle either.
So why are we here? Because of what he filed on April 23.
Three Trades, One Day, One Problem
On April 23, 2026, Peters disclosed three trades simultaneously. Per his full disclosure record on Blind Trust, he sold Corteva Agriscience (CTVA) in the $15,000-$50,000 range, bought J.M. Smucker (SJM) in the $1,000-$15,000 range, and bought PepsiCo (PEP) in the $15,000-$50,000 range.
Two of those three trades connect to his committee work in a way that's at least worth reading twice.
Peters sits on the Senate Appropriations Committee's Agriculture, Rural Development, Food and Drug Administration, and Related Agencies subcommittee. Corteva Agriscience is one of the largest agricultural inputs companies in the United States: seeds, crop protection chemicals, the whole supply chain that feeds into everything the Agriculture subcommittee touches. He sold it. That sale now sits in the committee-overlap column of his trade record, carrying the only angle in this piece that qualifies as a genuine conflict-of-interest flag. The 30-day alpha on that sale came in at negative 5.6% versus the S&P 500, meaning the position moved against him after he exited. He sold, and the stock did better than the market in the following month.
PepsiCo is also flagged as a committee overlap trade, under Food and Beverage/Consumer. Peters bought PEP on the same day. Thirty-day alpha: positive 0.4%. Not dramatic. The position roughly tracked the market. But PepsiCo is a food and beverage giant, and the Agriculture subcommittee has a say in FDA-related appropriations and food policy. The overlap is real even if the return is not.
J.M. Smucker, the third trade, carries no committee overlap flag. It's just a buy.
The Alpha Record, Honestly
Before anyone makes this into a trading-genius narrative: the full scored sample doesn't support it. Peters has 9 scored trades. Five were positive versus the market. Four were negative. Mean 30-day alpha across all nine: negative 3.4%. He's underwater on the portfolio as a whole, at least over the windows we can measure.
The best individual trades in the record are a January 2026 purchase of Stanley Black and Decker (SWK), which returned 9.2% alpha over 30 days, and a January 2026 purchase of W. P. Carey (WPC), which returned 7.3% alpha. Neither carries a committee overlap. A November 2025 buy of Conagra Brands (CAG) added 3.8% alpha. Good trades. No obvious connection to his oversight role.
The worst trade in the record is an Organon sale in October 2025 that went negative 39.9% on a $1,000-$15,000 position. No committee overlap there either. Just a bad call. The Intel sale in December 2025 lost 5.8% alpha and does carry a Technology committee-overlap flag via his Commerce subcommittee work on Science, Manufacturing, and Competitiveness.
The honest summary: 5 of 9 positive, mean alpha negative 3.4%, four committee-overlap trades with mixed results. It's a senator with a diversified account that's had some rough patches and a few bright spots, two of which intersect with committees he sits on.
The Corteva Sale Is the One to Watch
Of everything in the April 23 cluster, the Corteva sale is the sharpest edge. Corteva is an agricultural sciences company. Peters is on the agriculture appropriations subcommittee. He sold between $15,000 and $50,000 worth of it. The stock then outperformed the market by enough to show up as negative 5.6% alpha on his record, meaning he would have been better off holding.
There are no flagged vote-trade overlaps in the data. No single committee vote dropped the week before or after the April 23 trade cluster. The timing doesn't have an obvious trigger to point at. What it has is a member with agriculture oversight jurisdiction making a move in an agriculture stock, on a day he also bought two food and beverage names. The system permits all of this. Members are required to disclose. They are not required to divest, recuse, abstain, blush, or explain themselves to anyone.
It's legal. That's the part that should bother you.
PepsiCo in the Agriculture Subcommittee's Shadow
The PepsiCo buy is softer as a story but worth naming. PepsiCo is a food and beverage company. The Agriculture, Rural Development, Food and Drug Administration, and Related Agencies subcommittee has jurisdiction over FDA appropriations. PepsiCo's product portfolio runs directly through FDA-regulated labeling, nutrition standards, and food safety frameworks. Peters bought $15,000 to $50,000 worth on April 23. The 30-day return was roughly flat versus the market, positive 0.4%.
There's no vote to point to, no specific bill that moved in the week surrounding the trade. But the committee overlap flag exists for a reason, and the reason is that a senator with appropriations power over the FDA buying into a company the FDA regulates is at minimum a fact the public record should contain.
Peters's office hasn't commented. We didn't ask, because we don't have human sources. The disclosures are public. The committee assignments are public. The math is just math.
What the Housing Bill Has to Do With Any of This
Directly? Nothing. Peters's housing advocacy and his brokerage account are running on parallel tracks that don't intersect in any way the data can connect. He voted for the ROAD to Housing Act three times because he co-sponsored it, not because he holds a homebuilder ETF.
But the housing bill is why his name is in the news today, and his trades are why Blind Trust is writing about him. The two things coexist the way they always do with sitting members: the public legislative record and the private financial record, filed separately, disclosed on different timelines, almost never discussed in the same sentence.
Peters's most recent trades are in food and agriculture. His most active committee work touches food and agriculture. He's also fighting the Postmaster General over voter access and shepherding a housing bill to the House floor. He contains multitudes. His portfolio contains Pepsi.
The full disclosure record is public. The receipts are public. Make of them what you make of them.